Effects of konjac glucomannan hydrolysates on the gut microflora of mice

被引:30
作者
Elamir, Abdulmnem A. [1 ]
Tester, Richard F. [2 ]
Al-Ghazzewi, Farage H. [2 ]
Kaal, Hakim Y. [1 ]
Ghalbon, Amna A. [3 ]
Elmegrahai, Najat A. [3 ]
Piggott, John R. [4 ]
机构
[1] Univ Al Fatah, Fac Agr, Tripoli, Libya
[2] Glasgow Caledonian Univ, Glycol Ltd, Glasgow, Lanark, Scotland
[3] Univ Al Fatah, Fac Pharm, Tripoli, Libya
[4] Univ Strathclyde, Royal Coll, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
关键词
Food products; Bacteria;
D O I
10.1108/00346650810906930
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Purpose - The aim of this study is to determine the effects of depolymerised mannans and specifically konjac glucomannan hydrolysates (GMH) on the colonic microflora of mice. Blood glucose and cholesterol were also measured. Design/methodology/approach - Two groups (n = 20) of 12-week old Wister mice were used for a period of 14 weeks. One group (treatment group) were fed diets containing 5 per cent konjac GMH dissolved in drinking water in addition to the control (group) standard diet. Faecal microflora, feed consumption, body weight, blood glucose and cholesterol were determined. Findings - The GMH promoted the growth of anaerobes and lactobacilli in the treatment group where this was statistically, highly significant (P < 0.001). Also, the hydrolysate was able to reduce highly significantly (P < 0.001) faecal Clostridium perfringens and Escherichia coli counts. A significant increase in average daily feed consumption (P < 0.05) and weekly body weight (P < 0.001) was found for the treatment group. The mean +/- SD (mmol/l) of blood glucose and cholesterol was lower in the treatment group. Originality/value - In addition to modulating the gut microflora, GMH seems to lower the blood glucose and cholesterol in mice. Although this needs to be verified by further studies, GMH could also be a candidate for possible treatment of subjects with high cholesterol and for diabetics.
引用
收藏
页码:422 / 429
页数:8
相关论文
共 30 条
[21]  
Matsuura Y, 1998, J NUTR SCI VITAMINOL, V44, P423, DOI 10.3177/jnsv.44.423
[22]  
PASSARETTI S, 1991, ITAL J GASTROENTEROL, V23, P421
[23]   Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity [J].
Petrovsky, N .
VACCINE, 2006, 24 :S26-S29
[24]   Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data [J].
Pool-Zobel, BL .
BRITISH JOURNAL OF NUTRITION, 2005, 93 :S73-S90
[25]   Bacteria in the gut: Friends and foes and how to alter the balance [J].
Rastall, RA .
JOURNAL OF NUTRITION, 2004, 134 (08) :2022S-2026S
[26]   Effects of mannooligosaccharides from coffee mannan on fat storage in mice fed a high fat diet [J].
Takao, Izumi ;
Fujii, Shigeyoshi ;
Ishii, Asako ;
Han, Li-Kun ;
Kumao, Toshio ;
Ozaki, Kazuto ;
Asakawa, Atsushi .
JOURNAL OF HEALTH SCIENCE, 2006, 52 (03) :333-337
[27]  
WALSH DE, 1984, INT J OBESITY, V8, P289
[28]   Colonic health: Fermentation and short chain fatty acids [J].
Wong, JMW ;
de Souza, R ;
Kendall, CWC ;
Emam, A ;
Jenkins, DJA .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (03) :235-243
[29]   Advance in the applications of konjac glucomannan and its derivatives [J].
Zhang, YQ ;
Xie, BJ ;
Gan, X .
CARBOHYDRATE POLYMERS, 2005, 60 (01) :27-31
[30]  
ZHOU YZ, 1991, Z KLIN MED, V46, P1513